Page last updated: 2024-09-04

pixantrone and Leukemia, Plasmacytic

pixantrone has been researched along with Leukemia, Plasmacytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flögel, B; Greil, R; Jöhrer, K; Kircher, B; Willenbacher, E; Willenbacher, W	1

Reviews

1 review(s) available for pixantrone and Leukemia, Plasmacytic

Article	Year
Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia. Annals of hematology, 2019, Volume: 98, Issue:11 Topics: Aged; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Drug Synergism; Energy Metabolism; Female; Humans; Isoquinolines; Leukemia, Plasma Cell; Leukocytes, Mononuclear; Male; Middle Aged; Mitochondria; Multiple Myeloma; Panobinostat; Retrospective Studies	2019

Article

Year

Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.

Annals of hematology, 2019, Volume: 98, Issue:11

Topics: Aged; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Drug Synergism; Energy Metabolism; Female; Humans; Isoquinolines; Leukemia, Plasma Cell; Leukocytes, Mononuclear; Male; Middle Aged; Mitochondria; Multiple Myeloma; Panobinostat; Retrospective Studies

2019